Key terms
About TNDM
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest TNDM news
Apr 23
8:52am ET
Tandem Diabetes price target raised to $40 from $37 at Stifel
Apr 03
5:53am ET
Tandem Diabetes price target raised to $38 from $31 at Citi
Apr 02
9:00am ET
Analysts Are Bullish on These Healthcare Stocks: Tandem Diabetes Care (TNDM), Apyx Medical (APYX)
Mar 25
5:14pm ET
Tandem Diabetes upgraded to Buy at Stifel on strong Mobi adoption
Mar 25
5:06pm ET
Tandem Diabetes upgraded to Buy from Hold at Stifel
Mar 15
7:04am ET
Tandem Diabetes price target raised to $31 from $25 at Citi
Mar 06
8:55am ET
Tandem Diabetes Care (TNDM) Gets a Buy from Lake Street
Mar 05
8:47am ET
Craig-Hallum Sticks to Its Buy Rating for Tandem Diabetes Care (TNDM)
Mar 04
6:29pm ET
Tandem Diabetes announces private placement of $250M in convertible senior notes
Feb 28
11:14am ET
Tandem Diabetes (NASDAQ:TNDM): Investors Look to Innovation to Drive the Stock Higher
Feb 25
11:28pm ET
Tandem Diabetes Care Holds Steady: A Cautious Outlook Amidst Growth and Competitive Uncertainty
Feb 23
3:20am ET
Analysts Are Bullish on Top Healthcare Stocks: Intellia Therapeutics (NTLA), Tandem Diabetes Care (TNDM)
Feb 22
8:21am ET
Analysts Offer Insights on Healthcare Companies: Savara (SVRA), Harmony Biosciences Holdings (HRMY) and Tandem Diabetes Care (TNDM)
Feb 22
8:20am ET
Tandem Diabetes Care (TNDM) Gets a Hold from Stifel Nicolaus
Feb 22
8:11am ET
Piper Sandler Reaffirms Their Buy Rating on Tandem Diabetes Care (TNDM)
Feb 22
7:57am ET
Tandem Diabetes Care: Sell Rating Justified by Underwhelming Financials and Market Challenges
Feb 22
7:20am ET
Tandem Diabetes Care: Steady Growth Prospects and Hold Rating Amid Market Challenges
Feb 21
11:50pm ET
Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS) and Tandem Diabetes Care (TNDM)
Feb 21
4:09pm ET
Tandem Diabetes reports Q4 adjusted EPS (46c), consensus (25c)
Feb 20
8:45am ET
Lake Street Sticks to Their Buy Rating for Tandem Diabetes Care (TNDM)
Feb 20
8:39am ET
Tandem Diabetes Care (TNDM) Receives a Buy from Craig-Hallum
Feb 16
8:50am ET
Analysts Are Bullish on These Healthcare Stocks: LifeMD (LFMD), Tandem Diabetes Care (TNDM)
Feb 15
1:19am ET
Hold Rating on Tandem Diabetes Care Amidst Competitive Market and Mobi Launch Uncertainties
Feb 05
9:28am ET
Tandem Diabetes price target raised to $24 from $17 at Stifel
No recent press releases are available for TNDM
TNDM Financials
Key terms
Ad Feedback
TNDM Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
TNDM Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range